Collegium Pharmaceutical, Inc.COLLNASDAQ

Revenue (LTM)

$781M

+23.6% YoY

Net Income (LTM)

$63M

-9.1% YoY

Free Cash Flow

$328M

Revenue CAGR (5Y)

+20.3%

Marginsimproving

FCF$0.3B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	277	464↑67.6%	567↑22.2%	631↑11.4%	781↑23.6%
Gross Profit	151	209↑39.1%	326↑55.7%	377↑15.7%	463↑22.8%
Operating Income	18	33↑89.0%	167↑401.1%	170↑1.8%	187↑10.1%
Net Income	72	-25↓135.0%	48↑292.6%	69↑43.7%	63↓9.1%
EBITDA	87	173↑100.2%	308↑77.9%	342↑10.8%	401↑17.4%
EPS Diluted	1.86	-0.74↓139.8%	1.29↑274.3%	1.86↑44.2%	1.73↓7.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	186	174↓6.8%	239↑37.6%	71↓70.5%	251↑255.8%
Total Current Assets	316	420↑33.1%	538↑28.0%	482↓10.3%	691↑43.4%
Total Assets	692	1,174↑69.7%	1,143↓2.6%	1,664↑45.5%	1,657↓0.4%
Total Current Liabilities	280	434↑55.1%	458↑5.6%	510↑11.3%	440↓13.6%
Total Liabilities	489	979↑100.2%	948↓3.2%	1,435↑51.4%	1,355↓5.5%
Total Equity	203	195↓4.0%	195↑0.3%	229↑17.1%	302↑31.8%
Total Debt	259	709↑174.1%	674↓4.9%	859↑27.4%	941↑9.5%
Net Debt	72	535↑640.4%	435↓18.7%	789↑81.2%	689↓12.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	104	124↑20.0%	275↑121.2%	205↓25.4%	329↑60.7%
Capital Expenditure	-2	-2↑16.6%	-0↑71.6%	-2↓258.4%	-2↓5.3%
Free Cash Flow	102	123↑20.7%	274↑123.7%	203↓25.9%	328↑61.1%
Stock-Based Comp	24	23↓5.7%	27↑18.6%	32↑19.4%	42↑29.3%
Net Change in Cash	12	-13↓203.5%	64↑600.5%	-143↓324.9%	156↑208.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance